MassDevice.com +5 | The top 5 medtech stories for November 9, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Aum Cardiovascular releases preliminary data from Turbulence study Aum Cardiovascular today released preliminary results from the pivotal clinical trial of its Cadence heart disease diagnostics device, touting the device’s efficacy at detecting significant obstructive coronary artery disease. Aum’s Cadence is designed to identify obstructions in the coronary arteries by detecting acoustic signals generated by the turbulence created as blood flows past the obstruction, according to the company. Read more 4. Court quashes American Medical Systems subpoenas in pelvic mesh case, to mull sanctions The federal court overseeing the multidistrict litigation over pelvic mesh products made by American Medical Systems, the erstwhile women’s health business once owned by Endo International, is mulling sanctions on the company after quashing a 2nd round of subpoenas sent to an outside witness. Endo, which acquired AMS in 2011 for $2.9 billion, in 2015 dealt the men’s urology portion of the business to Boston Scientific for $1.65 billion. In March of this year the company shut d...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news